Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: A population-based study

Some, but not most, schizophrenia patients have below-average intelligence years before they manifest psychosis. However, it is not clear if those whose intelligence falls within-normal-range nevertheless have cognitive abnormalities. We examined the association between intra-individual variability in intellectual performance and risk for schizophrenia in individuals with normal IQ. 555,326 adolescents, mandatory assessed by the Israeli Draft Board were followed up over 8 to 17 years for psychiatric hospitalization by means of the Israeli National Psychiatric Hospitalization Case Registry. Data were available on 4 intelligence sub-tests, and on behavioral and psychosocial variables. Variability was computed from the variance of the four intelligence tests' standardized scores. There was a significant monotonic association between increased intra-individual variability in intellectual performance and risk of schizophrenia in individuals with within-normal-range IQ. Individuals with the highest variability were 3.8 times more likely to have schizophrenia [95%CI: 2.32–6.08; p < 0.0001] compared with individuals with the lowest variability. This association held after controlling for the effects of potential confounders. Despite within-normal-range premorbid IQ, apparently healthy adolescents who will later on manifest schizophrenia, nevertheless have cognitive abnormalities such as increased variability across intellectual tasks, possibly related to frontal lobe abnormalities

The mechanism behind SnO metallization under high pressure

SnO is known to undergo metallization at ∼ 5 GPa while retaining its tetragonal symmetry. However, the mechanism of this metallization remains speculative. We present a combined experimental and computational study including pressure-dependent infrared spectroscopy, resistivity, and neutron powder diffraction measurements. We show that, while the excess charge mobility increases with pressure, the lattice distortion, in terms of the z-position of Sn, is reduced. Both processes follow a similar trend that consists of two stages, a moderate increment up to ∼ 3 GPa followed by a rapid increase at higher pressure. This behavior is discussed in terms of polaron delocalization. The pressure-induced delocalization is dictated by the electron–phonon coupling and related local anisotropic lattice distortion at the polaron site. We show that these polaronic states are stable at 0 GPa with a binding energy of ∼ 0.35 eV. Upon increasing the pressure, the polaron binding energy is reduced with the electron–phonon coupling strength of Γ and M modes, enabling the electrical phase transition to occur at ∼ 3.8 GPa. Further compression increases the total electron–phonon coupling strength up to a maximum at 10 GPa, which is a strong evidence of dome-shaped superconductivity transition with Tc = 1.67 K

Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST):a prospective multicentre feasibility study protocol in patients and their caregivers

Abstract Introduction: Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia. In the European Union, approximately 40% of people with schizophrenia have TRS. Factors such as the persistence of positive symptoms or higher risk of comorbidities leave clinicians with a complex scenario when treating these patients. Intervention strategies based on mHealth have demonstrated their ability to support and promote self-management-based strategies. Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST), an innovative mHealth solution based on novel technology and offering high modular and flexible functioning, has been developed specifically for patients with TRS and their caregivers. As intervention in TRS is a challenge, it is necessary to perform a feasibility study before the cost-effectiveness testing stage. Methods and analysis: This manuscript describes the protocol for a prospective multicentre feasibility study in 45 patients with TRS and their caregivers who will be attended in the public health system of three localities: Hospital Santa Creu Sant Pau (Spain), Semmelweis University (Hungary) and Gertner Institute &amp; Sheba Medical Center (Israel). The primary aim is to investigate the feasibility and acceptability of the m-RESIST solution, configured by three mHealth tools: an app, wearable and a web-based platform. The solution collects data about acceptability, usability and satisfaction, together with preliminary data on perceived quality of life, symptoms and economic variables. The secondary aim is to collect preliminary data on perceived quality of life, symptoms and economic variables. Ethics and dissemination: This study protocol, funded by the Horizon 2020 Programme of the European Union, has the approval of the ethics committees of the participating institutions. Participants will be fully informed of the purpose and procedures of the study, and signed inform consents will be obtained. The results will be published in peer-reviewed journals and presented in scientific conferences to ensure widespread dissemination. Trial registration number: NCT03064776; Pre-results

Premorbid Intellectual Functioning and Risk of Schizophrenia and Spectrum Disorders

Evidence from longitudinal studies indicates that lower IQ score in childhood and early adolescence increases risk of schizophrenia and schizophrenia spectrum disorders (SSD). This study investigated the association between premorbid IQ and risk of SSD in a population-based cohort of 17-year-old conscripts. Fifty four thousand males assessed by the Israeli Draft Board during two consecutive years were followed by means of the Israeli National Psychiatric Hospitalization Case Registry for up to 11 years. Tests of verbal and non-verbal reasoning, mathematical knowledge and instructions comprehension and several psychosocial variables were recorded by the Draft Board. Risk for SSD increased with decreasing IQ score. Only poorer non-verbal reasoning conferred a significant increased risk for SSD after taking into account general intellectual ability. IQ was not associated with age of onset. These results confirm the importance of low intellectual functioning as a risk factor for SSD. This is unlikely to be due to prodrome